Foreign institutional research active, high-growth sectors such as AI semiconductors are favored.

robot
Abstract generation in progress
Mars Finance News: Since 2026 through June 19, foreign institutional investors have frequently carried out research activities on A-share listed companies. Companies in technology tracks such as semiconductors and electronic equipment, as well as those in the medical and high-end manufacturing sectors, have become key targets of foreign scrutiny. Judging by industry distribution, foreign research has been highly concentrated on three major areas: first, semiconductor and chip-related companies, including Lankit Technology, China Resources Micro, and Anji Technology; second, the medical device and innovative drug sectors, with Biocytogen, Mindray Medical, and United Imaging Healthcare receiving sustained attention; and third, high-end equipment manufacturing enterprises represented by Daijin Heavy Industry and Huajin Technology, which are also closely followed by foreign institutions. Industry insiders believe that the intensity of foreign research is an important signal of their long-term allocation intent. The AI industry chain, technological autonomy and controllability, and high-end manufacturing are still the main lines of foreign investment in China’s market. (China Securities Golden Bull)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned